155 related articles for article (PubMed ID: 14634564)
1. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis.
Makrydimas G; Sotiriadis A; Ioannidis JP
Am J Obstet Gynecol; 2003 Nov; 189(5):1330-5. PubMed ID: 14634564
[TBL] [Abstract][Full Text] [Related]
2. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers.
Makrydimas G; Sotiriadis A; Huggon IC; Simpson J; Sharland G; Carvalho JS; Daubeney PE; Ioannidis JP
Am J Obstet Gynecol; 2005 Jan; 192(1):89-95. PubMed ID: 15672008
[TBL] [Abstract][Full Text] [Related]
3. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies.
Müller MA; Clur SA; Timmerman E; Bilardo CM
Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215
[TBL] [Abstract][Full Text] [Related]
4. Nuchal translucency and congenital heart defects: heart failure or not?
Simpson JM; Sharland GK
Ultrasound Obstet Gynecol; 2000 Jul; 16(1):30-6. PubMed ID: 11084962
[TBL] [Abstract][Full Text] [Related]
5. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
[TBL] [Abstract][Full Text] [Related]
6. Association between increased nuchal translucency and second trimester cardiac echogenic foci.
Prefumo F; Presti F; Thilaganathan B; Carvalho JS
Obstet Gynecol; 2003 May; 101(5 Pt 1):899-904. PubMed ID: 12738147
[TBL] [Abstract][Full Text] [Related]
7. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
Baś-Budecka E; Perenc M; Sieroszewski P
Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
[TBL] [Abstract][Full Text] [Related]
8. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.
Hyett J; Perdu M; Sharland G; Snijders R; Nicolaides KH
BMJ; 1999 Jan; 318(7176):81-5. PubMed ID: 9880278
[TBL] [Abstract][Full Text] [Related]
9. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study.
McAuliffe FM; Hornberger LK; Winsor S; Chitayat D; Chong K; Johnson JA
Am J Obstet Gynecol; 2004 Oct; 191(4):1486-90. PubMed ID: 15507988
[TBL] [Abstract][Full Text] [Related]
10. Cardiac malformations in first-trimester fetuses with increased nuchal translucency: ultrasound diagnosis and postmortem morphology.
Haak MC; Bartelings MM; Gittenberger-De Groot AC; Van Vugt JM
Ultrasound Obstet Gynecol; 2002 Jul; 20(1):14-21. PubMed ID: 12100412
[TBL] [Abstract][Full Text] [Related]
11. First-trimester ductus venosus screening for cardiac defects: a meta-analysis.
Papatheodorou SI; Evangelou E; Makrydimas G; Ioannidis JP
BJOG; 2011 Nov; 118(12):1438-45. PubMed ID: 21668765
[TBL] [Abstract][Full Text] [Related]
12. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
[TBL] [Abstract][Full Text] [Related]
13. Outcome of fetuses with increased nuchal translucency.
Bilardo CM; Müller MA; Pajkrt E
Curr Opin Obstet Gynecol; 2001 Apr; 13(2):169-74. PubMed ID: 11315872
[TBL] [Abstract][Full Text] [Related]
14. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects.
Bahado-Singh RO; Wapner R; Thom E; Zachary J; Platt L; Mahoney MJ; Johnson A; Silver RK; Pergament E; Filkins K; Hogge WA; Wilson RD; Jackson LG;
Am J Obstet Gynecol; 2005 May; 192(5):1357-61. PubMed ID: 15902108
[TBL] [Abstract][Full Text] [Related]
15. First trimester screening for structural fetal abnormalities: nuchal translucency sonography.
Devine PC; Malone FD
Semin Perinatol; 1999 Oct; 23(5):382-92. PubMed ID: 10551791
[TBL] [Abstract][Full Text] [Related]
16. The role of fetal nuchal translucency in prenatal screening.
Snijders R; Smith E
Curr Opin Obstet Gynecol; 2002 Dec; 14(6):577-85. PubMed ID: 12441696
[TBL] [Abstract][Full Text] [Related]
17. Fetal Tricuspid Regurgitation in the First Trimester as a Screening Marker for Congenital Heart Defects: Systematic Review and Meta-Analysis.
Scala C; Morlando M; Familiari A; Leone Roberti Maggiore U; Ferrero S; D'Antonio F; Khalil A
Fetal Diagn Ther; 2017; 42(1):1-8. PubMed ID: 28482343
[TBL] [Abstract][Full Text] [Related]
18. Ductus venosus flow velocities in relation to the cardiac defects in first-trimester fetuses with enlarged nuchal translucency.
Haak MC; Twisk JW; Bartelings MM; Gittenberger-de Groot AC; van Vugt JM
Am J Obstet Gynecol; 2003 Mar; 188(3):727-33. PubMed ID: 12634648
[TBL] [Abstract][Full Text] [Related]
19. Nuchal Translucency and Congenital Heart Defects.
Sofia-Gonçalves A; Guedes-Martins L
Curr Cardiol Rev; 2024; 20(2):1-13. PubMed ID: 38275068
[TBL] [Abstract][Full Text] [Related]
20. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency.
Zosmer N; Souter VL; Chan CS; Huggon IC; Nicolaides KH
Br J Obstet Gynaecol; 1999 Aug; 106(8):829-33. PubMed ID: 10453834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
